To collect additional confirmatory data on alteplase(rt-PA) in the European setting and to
demonstrate that the treatment of patients between 3 and 4.30 hours of onset of symptoms of
acute ischemic stroke with rt-PA compared to placebo-treated patients will result in an
improved clinical outcome without increase of fatality rate.